The pan-Canadian Pharmaceutical Alliance (pCPA) conducts joint provincial/territorial/federal negotiations for brand name generic drugs in Canada to achieve greater value for publicly funded drug programs and patients through the use of the combined negotiating power of participating jurisdictions. The pCPA’s mandate is to enhance patient access to clinically relevant and cost-effective drug treatment options.
The Governing Council of the pCPA has procured an external consulting company (I2C) to undertake an independent evaluation of the organization. The objective of this project is to evaluate the pCPA’s performance against its stated mandate and provide recommendations to strengthen its role.
A key component of the evaluation is a survey of patients and the public to understand perspectives on obtaining prescription drugs through public drug programs.
Here’s where you can help! Complete their online survey. Participation is voluntary and anonymous. The survey should take about 10 minutes to complete. The survey is open until April 30th, 2020.